Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization

European Journal of Immunology

Volumn 41, Issue 4, 2011, Pages 1004-1013

  del Carmen Sancho Serra, Maria ^a   Simarro, Maria ^b   Castells, Mariana ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Desensitization; DNP OVA; Fc RI; IgE; Mast cells

Indexed keywords

12 HYDROXYHEPTADECATRIENOIC ACID; 2,4 DINITROPHENOL; ANTIGEN; CALCIUM; FC EPSILON RECEPTOR I; FC RECEPTOR; HUMAN SERUM ALBUMIN; HYDROXY FATTY ACID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 6; LEUKOTRIENE B4; LEUKOTRIENE C4; MITOGEN ACTIVATED PROTEIN KINASE P38; OVALBUMIN; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CALCIUM TRANSPORT; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DESENSITIZATION; INTERNALIZATION; MALE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPRODUCIBILITY;

ANIMALS; ANTIGENS; CELLS, CULTURED; DINITROBENZENES; IMMUNOGLOBULIN E; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; RECEPTORS, IGE; TIME FACTORS;

EID: 79953038437     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040810     Document Type: Article

References (33)

1. Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H. and Sullivan, T., Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N. Engl. J. Med. 1987. 316: 1622-1626.
2. Vadas, P., Gold, M., Perelman, B., Liss, G. M., Lack, G., Blyth, T., Simons, K. J. et al., Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N. Engl. J. Med. 2008. 358: 28-35.
3. Castells, M. C., Desensitization for drug allergy. Curr. Opin. Allergy Clin. Immunol. 2006. 6: 476-481.
4. Lee, C. W., Matulonis, U. A. and Castells, M. C., Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses. Gynecol. Oncol. 2005. 99: 393-399.
5. Castells, M. C., Tennant, N. M., Sloane, D. E., Hsu, F. I., Barrett, N. A., Hong, D. I., Laidlaw, T. M. et al., Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J. Allergy Clin. Immunol. 2008. 122: 574-580.
6. Meglio, P., Giampietro, P. G., Gianni, S. and Galli, E., Oral desensitization in children with immunoglobulin E-mediated cow's milk allergy-follow-up at 4 yr and 8 months. Pediatr. Allergy Immunol. 2008. 19: 412-419.
7. Mansfield, L., Successful oral desensitization for systemic peanut allergy. Ann. Allergy Asthma Immunol. 2006. 97: 266-267.
8. Lee, C. W., Matulonis, U. A. and Castells, M. C., Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol. Oncol. 2004. 95: 370-376.
9. Kraft, S. and Kinet, J. P., New developments in FcepsilonRI regulation, function and inhibition. Nat. Rev. Immunol. 2007. 7: 365-378.
10. Gilfillan, A. M. and Rivera, J., The tyrosine kinase network regulating mast cell activation. Immunol. Rev. 2009. 228: 149-169.
11. Ishizaka, T., Sterk, A. R., Daeron, M., Becker, E. L. and Ishizaka, K., Biochemical analysis of desensitization of mouse mast cells. J. Immunol. 1985. 135: 492-501.
12. Shalit, M. and Levi-Schaffer, F., Challenge of mast cells with increasing amounts of antigen induces desensitization. Clin. Exp. Allergy 1995. 25: 896-902.
13. Rubinchik, E., Shalit, M. and Levi-Schaffer, F., Responsiveness of human skin mast cells to repeated activation: an in vitro study. Allergy 1998. 53: 14-19.
14. MacGlashan, D., Jr., Desensitization of IgE-mediated IL-4 release from human basophils. J. Leukoc. Biol. 1998. 63: 59-67.
15. Kepley, C. L., Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Int. Arch. Allergy Immunol. 2005. 138: 29-39.
16. Morales, A. R., Shah, N. and Castells, M., Antigen-IgE desensitization in signal transducer and activator of transcription 6-deficient mast cells by suboptimal doses of antigen. Ann. Allergy Asthma Immunol. 2005. 94: 575-580.
17. Ma, H. T. and Beaven, M. A., Regulation of Ca2+signaling with particular focus on mast cells. Crit. Rev. Immunol. 2009. 129: 155-186.
18. Malaviya, R. and Uckun, F. M., Role of STAT6 in IgE receptor/FcepsilonRI-mediated late phase allergic responses of mast cells. J. Immunol. 2002. 168: 421-426.
19. Kalesnikoff, J., Baur, N., Leitges, M., Hughes, M. R., Damen, J. E., Huber, M. and Krystal, G., SHIP negatively regulates IgE+antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity. J. Immunol. 2002. 168: 4737-4746.
20. Ishizuka, T., Terada, N., Gerwins, P., Hamelmann, E., Oshiba, A., Fanger, G. R., Johnson, G. L. et al., Mast cells tumor necrosis factor alpha production is regulated by MEK kinases. Proc. Natl. Acad. Sci. USA 1997. 94: 6358-6363.
21. Fattakhova, G. V., Masilamani, M., Narayanan, S., Borrego, F., Gilfillan, A. M., Metcalfe, D. D. and Coligan, J. E., Endosomal trafficking of the ligated FcεRI receptor. Mol. Immunol. 2009. 46: 793-802.
22. Mao, S. Y., Pfeiffer, J. R., Oliver, J. M. and Metzger, H., Effects of subunit mutation on the localization to coated pits and internalization of cross-linked IgE-receptor complexes. J. Immunol. 1993. 151: 2760-2774.
23. Kambayashi, T., Baranski, J. D., Baker, R. G., Zou, T., Allenspach, E. J., Shoag, J. E., Jones, P. L. et al., Indirect involvement of allergen-captured mast cells in antigen presentation. Blood 2008. 111: 1489-1496.
24. Gonzalez-Espinosa, C., Odom, S., Olivera, A., Hobson, J. P., Cid Martinez, M. E., Olivera-dos-Santos, A., Barra, L. et al., Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J. Exp. Med. 2003. 197: 1453-1465.
25. Andrews, N. L., Pfeiffer, J. R., Martinez, A. M., Haaland, D. M., Davis, R. W., Kawakami, T., Oliver, J. M. et al., Small, mobile FcεRI receptor aggregates are signaling competent. Immunity 2009. 31: 469-479.
26. MacGlashan, D., Jr. and Lichtenstein, L. M., Basic characteristics of human lung mast cell desensitization. J. Immunol. 1987. 139: 501-505.
27. MacGlashan, D., Jr. and Undem, B. J., Inducing an anergic state in mast cells and basophils without secretion. J. Allergy Clin. Immunol. 2008. 121: 1500-1506.
28. Ozawa, T., Nakata, K., Mizuno, K. and Yakura, H., Negative autoregulation of Src homology region 2-domain-containing phosphatase-1 in rat basophilic leukemia-2H3 cells. Int. Immunol. 2007. 19: 1049-1061.
29. Lu-Kuo, J. M., Joyal, D. M., Austen, K. F. and Katz, H. R., gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. J. Biol. Chem. 1999. 274: 5791-5796.
30. Castells, M. C., Klickstein, L. B., Hassani, K., Cumplido, J. A., Lacouture, M. E., Austen, K. F. and Katz, HR., gp49B1-alpha(v)beta3 interaction inhibits antigen-induced mast cell activation. Nat. Immunol. 2001. 2: 436-442.
31. Yokota, T., Lee, F., Rennick, D., Hall, C., Arai, N., Mosmann, T., Nabel, G. et al., Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells. Proc. Natl. Acad. Sci. USA 1984. 81: 1070-1074.
32. Niwa, H., Yamamura, K. and Miyazaki, J., Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991. 108: 193-199.
33. Hsieh, F. H., Lam, B. K., Penrose, J. F., Austen, K. F. and Boyce, J. A., T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. J. Exp. Med. 2001. 193: 123-133.